Clinical Trials Logo
  1. Home
  2. Infections, Respiratory Tract
  3. NCT00354965

Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients

Infections, Respiratory Tract Clinical Trial

Official title:
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days

Clinical Trial Summary

Clinical research study to test amoxicillin and clavulanate tablet formulation for use in Acute Bacterial Sinusitis (ABS) in adolescent patients weighing at least 40 kilogram (kg) and no more than 16 years old. ABS is an acute bacterial infection of the sinus. The purpose of this study is to find out how children tolerate Augmentin XR and what happens to Augmentin XR in the body after it has been swallowed by children.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00354965
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 1
Start date January 19, 2006
Completion date April 2, 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT02202187 - A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers Phase 1
Completed NCT02257398 - Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers Phase 1
Completed NCT01706315 - This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects Phase 1
Completed NCT02000765 - A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects Phase 1
Completed NCT04600752 - Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India Phase 4
Terminated NCT01292213 - A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom N/A
Completed NCT01772238 - Bioequivalence Study of an Amoxicillin-Clavulanic Phase 1
Completed NCT01615796 - Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses Phase 1
Completed NCT02169583 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects Phase 1
Completed NCT01353768 - Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study N/A
Completed NCT01767571 - Bioequivalence Study of Cephalexin Suspension 250 Phase 1
Completed NCT01767532 - Bioequivalence Study of Cephalexin Suspension 125 Phase 1
Completed NCT01510938 - Probiotics in Respiratory Tract Infections in Children Phase 2
Completed NCT02688361 - A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution Phase 1
Withdrawn NCT02678234 - An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu Phase 3
Withdrawn NCT02730364 - An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu Phase 3
Completed NCT01767584 - Bioequivalence Study of Cephalexin Tablets 1g Phase 1